scispace - formally typeset
Search or ask a question
Author

Simon de Lusignan

Bio: Simon de Lusignan is an academic researcher from University of Oxford. The author has contributed to research in topics: Population & Medicine. The author has an hindex of 50, co-authored 447 publications receiving 9414 citations. Previous affiliations of Simon de Lusignan include St George's, University of London & University of Surrey.


Papers
More filters
Journal ArticleDOI
Simone Wahl, Alexander W. Drong1, Benjamin Lehne2, Marie Loh3, Marie Loh4, Marie Loh2, William R. Scott2, William R. Scott5, Sonja Kunze, Pei-Chien Tsai6, Janina S. Ried, Weihua Zhang2, Weihua Zhang7, Youwen Yang2, Sili Tan8, Giovanni Fiorito9, Lude Franke10, Simonetta Guarrera9, Silva Kasela11, Jennifer Kriebel, Rebecca C Richmond12, Marco Adamo13, Uzma Afzal2, Uzma Afzal7, Mika Ala-Korpela14, Mika Ala-Korpela4, Mika Ala-Korpela12, Benedetta Albetti15, Ole Ammerpohl16, Jane F. Apperley2, Marian Beekman17, Pier Alberto Bertazzi15, S. Lucas Black2, Christine Blancher1, Marc Jan Bonder10, Mario Brosch18, Maren Carstensen-Kirberg19, Anton J. M. de Craen17, Simon de Lusignan20, Abbas Dehghan21, Mohamed Elkalaawy13, Krista Fischer11, Oscar H. Franco21, Tom R. Gaunt12, Jochen Hampe18, Majid Hashemi13, Aaron Isaacs21, Andrew Jenkinson13, Sujeet Jha22, Norihiro Kato, Vittorio Krogh, Michael Laffan2, Christa Meisinger, Thomas Meitinger23, Zuan Yu Mok8, Valeria Motta15, Hong Kiat Ng8, Zacharoula Nikolakopoulou5, Georgios Nteliopoulos2, Salvatore Panico24, Natalia Pervjakova11, Holger Prokisch23, Wolfgang Rathmann19, Michael Roden19, Federica Rota15, Michelle Ann Rozario8, Johanna K. Sandling25, Johanna K. Sandling26, Clemens Schafmayer, Katharina Schramm23, Reiner Siebert16, Reiner Siebert27, P. Eline Slagboom17, Pasi Soininen4, Pasi Soininen14, Lisette Stolk21, Konstantin Strauch28, E-Shyong Tai8, Letizia Tarantini15, Barbara Thorand, Ettje F. Tigchelaar10, Rosario Tumino, André G. Uitterlinden21, Cornelia M. van Duijn21, Joyce B. J. van Meurs21, Paolo Vineis, Ananda R. Wickremasinghe29, Cisca Wijmenga10, Tsun-Po Yang26, Wei Yuan6, Wei Yuan30, Alexandra Zhernakova10, Rachel L. Batterham13, George Davey Smith12, Panos Deloukas26, Panos Deloukas31, Panos Deloukas32, Bastiaan T. Heijmans17, Christian Herder19, Albert Hofman21, Cecilia M. Lindgren1, Cecilia M. Lindgren33, Lili Milani11, Pim van der Harst10, Annette Peters, Thomas Illig, Caroline L Relton12, Melanie Waldenberger, Marjo-Riitta Järvelin34, Valentina Bollati15, Richie Soong8, Tim D. Spector6, James Scott5, Mark I. McCarthy35, Mark I. McCarthy36, Mark I. McCarthy1, Paul Elliott2, Paul Elliott37, Jordana T. Bell6, Giuseppe Matullo9, Christian Gieger, Jaspal S. Kooner5, Harald Grallert, John C. Chambers 
05 Jan 2017-Nature
TL;DR: In this article, the authors used epigenome-wide association to show that body mass index (BMI), a key measure of adiposity, is associated with widespread changes in DNA methylation.
Abstract: Approximately 1.5 billion people worldwide are overweight or affected by obesity, and are at risk of developing type 2 diabetes, cardiovascular disease and related metabolic and inflammatory disturbances1,2. Although the mechanisms linking adiposity to associated clinical conditions are poorly understood, recent studies suggest that adiposity may influence DNA methylation3,4,5,6, a key regulator of gene expression and molecular phenotype7. Here we use epigenome-wide association to show that body mass index (BMI; a key measure of adiposity) is associated with widespread changes in DNA methylation (187 genetic loci with P < 1 × 10−7, range P = 9.2 × 10−8 to 6.0 × 10−46; n = 10,261 samples). Genetic association analyses demonstrate that the alterations in DNA methylation are predominantly the consequence of adiposity, rather than the cause. We find that methylation loci are enriched for functional genomic features in multiple tissues (P < 0.05), and show that sentinel methylation markers identify gene expression signatures at 38 loci (P < 9.0 × 10−6, range P = 5.5 × 10−6 to 6.1 × 10−35, n = 1,785 samples). The methylation loci identify genes involved in lipid and lipoprotein metabolism, substrate transport and inflammatory pathways. Finally, we show that the disturbances in DNA methylation predict future development of type 2 diabetes (relative risk per 1 standard deviation increase in methylation risk score: 2.3 (2.07–2.56); P = 1.1 × 10−54). Our results provide new insights into the biologic pathways influenced by adiposity, and may enable development of new strategies for prediction and prevention of type 2 diabetes and other adverse clinical consequences of obesity.

667 citations

Journal ArticleDOI
TL;DR: People living in urban areas versus rural areas and in more deprived areas and people with chronic kidney disease were more likely to test positive in the adjusted analysis, and active smoking was linked with decreased odds of a positive test result.
Abstract: Summary Background There are few primary care studies of the COVID-19 pandemic. We aimed to identify demographic and clinical risk factors for testing positive for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) within the Oxford Royal College of General Practitioners (RCGP) Research and Surveillance Centre primary care network. Methods We analysed routinely collected, pseudonymised data for patients in the RCGP Research and Surveillance Centre primary care sentinel network who were tested for SARS-CoV-2 between Jan 28 and April 4, 2020. We used multivariable logistic regression models with multiple imputation to identify risk factors for positive SARS-CoV-2 tests within this surveillance network. Findings We identified 3802 SARS-CoV-2 test results, of which 587 were positive. In multivariable analysis, male sex was independently associated with testing positive for SARS-CoV-2 (296 [18·4%] of 1612 men vs 291 [13·3%] of 2190 women; adjusted odds ratio [OR] 1·55, 95% CI 1·27–1·89). Adults were at increased risk of testing positive for SARS-CoV-2 compared with children, and people aged 40–64 years were at greatest risk in the multivariable model (243 [18·5%] of 1316 adults aged 40–64 years vs 23 [4·6%] of 499 children; adjusted OR 5·36, 95% CI 3·28–8·76). Compared with white people, the adjusted odds of a positive test were greater in black people (388 [15·5%] of 2497 white people vs 36 [62·1%] of 58 black people; adjusted OR 4·75, 95% CI 2·65–8·51). People living in urban areas versus rural areas (476 [26·2%] of 1816 in urban areas vs 111 [5·6%] of 1986 in rural areas; adjusted OR 4·59, 95% CI 3·57–5·90) and in more deprived areas (197 [29·5%] of 668 in most deprived vs 143 [7·7%] of 1855 in least deprived; adjusted OR 2·03, 95% CI 1·51–2·71) were more likely to test positive. People with chronic kidney disease were more likely to test positive in the adjusted analysis (68 [32·9%] of 207 with chronic kidney disease vs 519 [14·4%] of 3595 without; adjusted OR 1·91, 95% CI 1·31–2·78), but there was no significant association with other chronic conditions in that analysis. We found increased odds of a positive test among people who are obese (142 [20·9%] of 680 people with obesity vs 171 [13·2%] of 1296 normal-weight people; adjusted OR 1·41, 95% CI 1·04–1·91). Notably, active smoking was linked with decreased odds of a positive test result (47 [11·4%] of 413 active smokers vs 201 [17·9%] of 1125 non-smokers; adjusted OR 0·49, 95% CI 0·34–0·71). Interpretation A positive SARS-CoV-2 test result in this primary care cohort was associated with similar risk factors as observed for severe outcomes of COVID-19 in hospital settings, except for smoking. We provide evidence of potential sociodemographic factors associated with a positive test, including deprivation, population density, ethnicity, and chronic kidney disease. Funding Wellcome Trust.

490 citations

Journal ArticleDOI
TL;DR: Internet-based surveys provide an attractive alternative to postal and telephone surveys of health professionals, but they raise important technical and methodological issues which should be carefully considered before widespread implementation.
Abstract: Results. The systematic review identified 17 Internet-based surveys of health professionals. Whilst most studies sampled from professional e-directories, some studies drew on unknown denominator populations by placing survey questionnaires on open web sites or electronic discussion groups. Twelve studies reported response rates, which ranged from nine to 94%. Sending follow-up reminders resulted in a substantial increase in response rates. In our own survey of GPs, a total of 268 GPs participated (adjusted response rate = 52.4%) after five e-mail reminders. A further 72 GPs responded to a brief telephone survey of non-respondents. Respondents to the Internet survey were more likely to be male and had significantly greater intentions to use Internet-based decision support than non-respondents. Conclusions. Internet-based surveys provide an attractive alternative to postal and telephone surveys of health professionals, but they raise important technical and methodological issues which should be carefully considered before widespread implementation. The major obstacle is external validity, and specifically how to obtain a representative sample and adequate response rate. Controlled access to a national list of NHSnet e-mail addresses of health professionals could provide a solution.

489 citations

Journal ArticleDOI
TL;DR: In this article, the authors investigated the association between the mass roll-out of the first doses of these COVID-19 vaccines and hospital admissions for CoV-19 and found that the first dose of the BNT162b2 mRNA vaccine was associated with a vaccine effect of 91% (95% CI 85-94) for reduced COVID19 hospital admission at 28-34 days post-vaccination.

437 citations

Journal ArticleDOI
John C. Chambers, Marie Loh1, Marie Loh2, Marie Loh3, Benjamin Lehne1, Alexander W. Drong4, Jennifer Kriebel, Valeria Motta5, Simone Wahl, Hannah R Elliott6, Hannah R Elliott1, Federica Rota5, William R. Scott1, William R. Scott7, Weihua Zhang8, Weihua Zhang1, Sian-Tsung Tan8, Sian-Tsung Tan7, Gianluca Campanella1, Marc Chadeau-Hyam1, Loic Yengo9, Loic Yengo10, Rebecca C Richmond6, Martyna Adamowicz-Brice11, Uzma Afzal8, Uzma Afzal1, Kiymet Bozaoglu12, Zuan Yu Mok13, Hong Kiat Ng13, François Pattou9, François Pattou14, Holger Prokisch15, Michelle Ann Rozario13, Letizia Tarantini5, James Abbott1, Mika Ala-Korpela, Benedetta Albetti5, Ole Ammerpohl16, Pier Alberto Bertazzi5, Christine Blancher17, R. Caiazzo6, R. Caiazzo12, John Danesh18, Tom R. Gaunt6, Simon de Lusignan19, Christian Gieger, Thomas Illig20, Sujeet Jha21, Simon Jones19, Jeremy B. M. Jowett12, Antti J. Kangas3, Anuradhani Kasturiratne22, Norihiro Kato, Navaratnam Kotea23, Sudhir Kowlessur, Janne Pitkäniemi24, Prakash P Punjabi25, Danish Saleheen26, Danish Saleheen18, Clemens Schafmayer, Pasi Soininen27, Pasi Soininen3, E-Shyong Tai13, Barbara Thorand, Jaakko Tuomilehto24, Ananda R. Wickremasinghe22, Soterios A. Kyrtopoulos, Timothy J. Aitman11, Christian Herder28, Jochen Hampe29, Stéphane Cauchi9, Stéphane Cauchi10, Caroline L Relton6, Philippe Froguel, Richie Soong13, Paolo Vineis1, Marjo-Riitta Järvelin, James Scott7, Harald Grallert, Valentina Bollati5, Paul Elliott1, Mark I. McCarthy17, Mark I. McCarthy4, Mark I. McCarthy30, Jaspal S. Kooner 
TL;DR: A nested case-control study of DNA methylation in Indian Asians and Europeans with incident type 2 diabetes who were identified from the 8-year follow-up of 25 372 participants in the London Life Sciences Prospective Population study.

384 citations


Cited by
More filters
01 Jan 2014
TL;DR: These standards of care are intended to provide clinicians, patients, researchers, payors, and other interested individuals with the components of diabetes care, treatment goals, and tools to evaluate the quality of care.
Abstract: XI. STRATEGIES FOR IMPROVING DIABETES CARE D iabetes is a chronic illness that requires continuing medical care and patient self-management education to prevent acute complications and to reduce the risk of long-term complications. Diabetes care is complex and requires that many issues, beyond glycemic control, be addressed. A large body of evidence exists that supports a range of interventions to improve diabetes outcomes. These standards of care are intended to provide clinicians, patients, researchers, payors, and other interested individuals with the components of diabetes care, treatment goals, and tools to evaluate the quality of care. While individual preferences, comorbidities, and other patient factors may require modification of goals, targets that are desirable for most patients with diabetes are provided. These standards are not intended to preclude more extensive evaluation and management of the patient by other specialists as needed. For more detailed information, refer to Bode (Ed.): Medical Management of Type 1 Diabetes (1), Burant (Ed): Medical Management of Type 2 Diabetes (2), and Klingensmith (Ed): Intensive Diabetes Management (3). The recommendations included are diagnostic and therapeutic actions that are known or believed to favorably affect health outcomes of patients with diabetes. A grading system (Table 1), developed by the American Diabetes Association (ADA) and modeled after existing methods, was utilized to clarify and codify the evidence that forms the basis for the recommendations. The level of evidence that supports each recommendation is listed after each recommendation using the letters A, B, C, or E.

9,618 citations

Book
01 Jan 1995
TL;DR: In this article, Nonaka and Takeuchi argue that Japanese firms are successful precisely because they are innovative, because they create new knowledge and use it to produce successful products and technologies, and they reveal how Japanese companies translate tacit to explicit knowledge.
Abstract: How has Japan become a major economic power, a world leader in the automotive and electronics industries? What is the secret of their success? The consensus has been that, though the Japanese are not particularly innovative, they are exceptionally skilful at imitation, at improving products that already exist. But now two leading Japanese business experts, Ikujiro Nonaka and Hiro Takeuchi, turn this conventional wisdom on its head: Japanese firms are successful, they contend, precisely because they are innovative, because they create new knowledge and use it to produce successful products and technologies. Examining case studies drawn from such firms as Honda, Canon, Matsushita, NEC, 3M, GE, and the U.S. Marines, this book reveals how Japanese companies translate tacit to explicit knowledge and use it to produce new processes, products, and services.

7,448 citations

Journal ArticleDOI
TL;DR: The 11th edition of Harrison's Principles of Internal Medicine welcomes Anthony Fauci to its editorial staff, in addition to more than 85 new contributors.
Abstract: The 11th edition of Harrison's Principles of Internal Medicine welcomes Anthony Fauci to its editorial staff, in addition to more than 85 new contributors. While the organization of the book is similar to previous editions, major emphasis has been placed on disorders that affect multiple organ systems. Important advances in genetics, immunology, and oncology are emphasized. Many chapters of the book have been rewritten and describe major advances in internal medicine. Subjects that received only a paragraph or two of attention in previous editions are now covered in entire chapters. Among the chapters that have been extensively revised are the chapters on infections in the compromised host, on skin rashes in infections, on many of the viral infections, including cytomegalovirus and Epstein-Barr virus, on sexually transmitted diseases, on diabetes mellitus, on disorders of bone and mineral metabolism, and on lymphadenopathy and splenomegaly. The major revisions in these chapters and many

6,968 citations

Journal ArticleDOI
01 Jan 2011-Stroke
TL;DR: In this paper, the authors provided evidence-based recommendations for the prevention of future stroke among survivors of ischemic stroke or transient ischemi-chemic attack, including the control of risk factors, intervention for vascular obstruction, antithrombotic therapy for cardioembolism, and antiplatelet therapy for noncardioembolic stroke.
Abstract: The aim of this updated guideline is to provide comprehensive and timely evidence-based recommendations on the prevention of future stroke among survivors of ischemic stroke or transient ischemic attack. The guideline is addressed to all clinicians who manage secondary prevention for these patients. Evidence-based recommendations are provided for control of risk factors, intervention for vascular obstruction, antithrombotic therapy for cardioembolism, and antiplatelet therapy for noncardioembolic stroke. Recommendations are also provided for the prevention of recurrent stroke in a variety of specific circumstances, including aortic arch atherosclerosis, arterial dissection, patent foramen ovale, hyperhomocysteinemia, hypercoagulable states, antiphospholipid antibody syndrome, sickle cell disease, cerebral venous sinus thrombosis, and pregnancy. Special sections address use of antithrombotic and anticoagulation therapy after an intracranial hemorrhage and implementation of guidelines.

4,545 citations

01 Jan 2020
TL;DR: Prolonged viral shedding provides the rationale for a strategy of isolation of infected patients and optimal antiviral interventions in the future.
Abstract: Summary Background Since December, 2019, Wuhan, China, has experienced an outbreak of coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Epidemiological and clinical characteristics of patients with COVID-19 have been reported but risk factors for mortality and a detailed clinical course of illness, including viral shedding, have not been well described. Methods In this retrospective, multicentre cohort study, we included all adult inpatients (≥18 years old) with laboratory-confirmed COVID-19 from Jinyintan Hospital and Wuhan Pulmonary Hospital (Wuhan, China) who had been discharged or had died by Jan 31, 2020. Demographic, clinical, treatment, and laboratory data, including serial samples for viral RNA detection, were extracted from electronic medical records and compared between survivors and non-survivors. We used univariable and multivariable logistic regression methods to explore the risk factors associated with in-hospital death. Findings 191 patients (135 from Jinyintan Hospital and 56 from Wuhan Pulmonary Hospital) were included in this study, of whom 137 were discharged and 54 died in hospital. 91 (48%) patients had a comorbidity, with hypertension being the most common (58 [30%] patients), followed by diabetes (36 [19%] patients) and coronary heart disease (15 [8%] patients). Multivariable regression showed increasing odds of in-hospital death associated with older age (odds ratio 1·10, 95% CI 1·03–1·17, per year increase; p=0·0043), higher Sequential Organ Failure Assessment (SOFA) score (5·65, 2·61–12·23; p Interpretation The potential risk factors of older age, high SOFA score, and d-dimer greater than 1 μg/mL could help clinicians to identify patients with poor prognosis at an early stage. Prolonged viral shedding provides the rationale for a strategy of isolation of infected patients and optimal antiviral interventions in the future. Funding Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences; National Science Grant for Distinguished Young Scholars; National Key Research and Development Program of China; The Beijing Science and Technology Project; and Major Projects of National Science and Technology on New Drug Creation and Development.

4,408 citations